NOW Foods Glycine Pure Powder review: is it worth it?

What is NOW Foods Glycine Pure Powder, and who makes it?

Glycine is the smallest amino acid the body uses, and it does double duty: it's a structural building block (it makes up roughly a third of the amino acids in collagen) and a signaling molecule in the central nervous system, where it acts as an inhibitory neurotransmitter in the brainstem and spinal cord and as a co-agonist at NMDA receptors. NOW Foods Glycine Pure Powder is simply that amino acid in isolated, free-form (unbound) powder, with no fillers, flavors, or added actives.

NOW Foods is a long-established Illinois-based supplement manufacturer (founded 1968) that owns its production and runs an in-house analytical lab. That matters in a category where third-party testing has repeatedly caught contamination and mislabeling: NOW's products are produced in GMP-certified facilities, and the company is unusual in publicly publishing lab results that flag competitors' adulterated products. For an unregulated category — the FDA does not approve dietary supplements for safety or efficacy before sale (FDA) — buying from a vertically integrated manufacturer with a public testing track record is a meaningful risk reducer.

The product is sold in a 1 lb (454 g) tub. Per the label, a serving is approximately 3/4 of a level teaspoon delivering 3 g (3,000 mg) of glycine, which works out to roughly 151 such servings per container. It is labeled Non-GMO, vegan, soy-free, and kosher. The powder is mildly sweet on its own (glycine tastes faintly sugary), which is why it dissolves acceptably into water or juice without added sweeteners.

How does glycine work for sleep?

This is where glycine is genuinely interesting, because the proposed mechanism is different from most sleep supplements. Melatonin shifts your circadian timing; antihistamines and many "PM" formulas sedate you. Glycine appears to work largely through thermoregulation.

Falling asleep is tightly coupled to a drop in core body temperature, achieved by shunting blood to the skin of the hands and feet (peripheral vasodilation) to dump heat. Animal research suggests oral glycine accelerates exactly this process. In a frequently cited rat study, oral glycine promoted non-REM sleep and lowered core body temperature (with increased cutaneous blood flow consistent with heat loss); these effects were abolished by lesioning the suprachiasmatic nucleus (the brain's master clock) and by NMDA-receptor antagonists, but not by a glycine-receptor antagonist (strychnine) — implicating NMDA receptors in the SCN as the relevant target (Kawai et al., *Neuropsychopharmacology* 2015; PMID 25533534). In other words, glycine seems to nudge the body's "time to cool down and sleep" signal rather than knocking you out.

A second, more speculative pathway is glycine's role as an inhibitory neurotransmitter, which could theoretically calm arousal. But the human studies were not designed to separate these mechanisms, so the thermoregulatory story — while plausible and supported by physiology — should still be read as the leading hypothesis rather than settled fact.

What is the evidence that glycine improves sleep?

Here HealthVetted has to be blunt: the human evidence base is small, mostly subjective, old, and dominated by a single corporate sponsor. It is suggestive, not definitive.

The foundational trial is Yamadera et al. (*Sleep and Biological Rhythms* 2007). It was a randomized, single-blinded crossover study in volunteers with ongoing unsatisfactory sleep, comparing 3 g of glycine versus placebo taken within an hour of bedtime. Glycine improved *subjective* sleep quality and sleep efficacy, and on polysomnography it shortened the time to fall asleep and the time to reach slow-wave (deep) sleep — without distorting overall sleep architecture. The notable caveats: it was small, only single-blinded (not double-blinded), and conducted by researchers affiliated with Ajinomoto, a major amino-acid manufacturer.

The second key study, Bannai et al. (*Frontiers in Neurology* 2012; PMID 22529837), is arguably more useful because it tested daytime function. Twelve healthy volunteers were sleep-restricted to 25% below their usual sleep for three consecutive nights and given 3 g of glycine or placebo before bed. Glycine significantly reduced reaction time on a psychomotor vigilance task (the most consistent objective finding, significant on both day 1 and day 3) and significantly improved self-reported daytime fatigue, though the fatigue benefit reached significance only on day 1, not day 3; there was a non-significant trend toward less sleepiness. This is the most interesting signal in the whole literature: the benefit may be less about the night and more about feeling and performing better the next day after imperfect sleep. Again, the study came from Ajinomoto-affiliated authors and was small.

What's missing is just as important as what exists. There is no large, independent, double-blind randomized trial and no Cochrane review or major meta-analysis establishing glycine as an effective treatment for insomnia. Most of the positive data trace back to one company's research group, sample sizes are in the dozens, and the strongest outcomes are subjective. Glycine is not recommended as a first-line therapy in major insomnia guidelines, which prioritize cognitive behavioral therapy for insomnia (CBT-I) (American Academy of Sleep Medicine). Treat the sleep claim as "low-risk, plausibly helpful for some people, but unproven at the level you'd demand of a drug."

What else does glycine do? (collagen, glutathione, metabolic roles)

Even setting sleep aside, glycine has well-established biochemical roles that explain why some people supplement it. It is a required substrate for synthesizing collagen (the most abundant protein in the body), glutathione (a major endogenous antioxidant, made from glycine, cysteine, and glutamate), creatine, and bile acids, and it participates in nitrogen and one-carbon metabolism.

Glycine is often called "conditionally essential." The body makes it from serine and other precursors, but several analyses argue endogenous synthesis (on the order of ~3 g/day) plus typical dietary intake (roughly 1.5–3 g/day) may fall short of total metabolic demand, particularly for collagen turnover. One frequently cited metabolic analysis (Meléndez-Hevia et al., *Journal of Biosciences* 2009) estimated a shortfall on the order of ~10 g/day relative to the needs of collagen synthesis alone in an adult. This is an area of active nutritional debate rather than settled consensus, and it should not be oversold. But it does mean a glycine supplement isn't only a "sleep" product; it's a general amino-acid top-up, which is partly why NOW also markets it for "energy production" and nervous-system support.

Glycine has also been studied as part of combination protocols (for example, glycine plus N-acetylcysteine to raise glutathione in older adults) and within metabolic-syndrome research, but those use cases go beyond a single-ingredient sleep powder and the evidence is preliminary.

Who is NOW Glycine Powder best for — and who should skip it?

Reasonable candidates:

• People with mild, occasional difficulty falling asleep or "unrefreshing" sleep who want a low-risk, non-sedating, non-habit-forming option to try.
• Shift workers, students, and others facing predictable short sleep who care most about next-day alertness — the Bannai daytime-function data is the most encouraging signal.
• People who want a cheap, clean, single-ingredient amino acid for general use (collagen/glutathione support) and don't want capsules or proprietary blends.
• Anyone who prefers powder for flexible dosing and easy mixing.

Who should skip it or get medical advice first:

• Anyone with chronic insomnia. Glycine is not a substitute for evaluation and CBT-I, the guideline-recommended first-line treatment.
• People taking clozapine — glycine and other NMDA co-agonists have been reported to potentially reduce clozapine's efficacy, so this combination warrants physician oversight.
• People with significant kidney or liver disease, who should clear any amino-acid supplementation with their clinician given the role these organs play in amino-acid handling.
• Pregnant or breastfeeding individuals, where supplemental (above-food) doses lack adequate safety data.
• Anyone expecting a knockout effect. Glycine is subtle; if you need reliable sedation, this is the wrong tool.

Is glycine safe? Side effects and interactions

Glycine has a strong safety profile at the doses in question. It is generally well tolerated, and the 3 g pre-bed dose used in the trials is far below intakes associated with problems. Research has used doses up to roughly 9 g/day, and short-term use in the multi-gram range is generally considered safe in healthy adults.

The most common adverse effects are gastrointestinal — mild nausea, soft stools or loose stools, or stomach upset — and these become more likely as the dose climbs (reports cluster around higher intakes, e.g., 15 g+ per day). Taking it with a little liquid and not stacking large doses helps. Because it's mildly sweet and osmotically active, very large single doses can have a mild laxative effect for some people.

Key safety points to keep in mind:

• Drug interactions are limited but real. The clearest concern is clozapine (above). Glycine is not known to interact dangerously with most common medications, but it can be additive with other sedatives or sleep aids in terms of subjective drowsiness; combining it with prescription hypnotics, alcohol, or other CNS depressants should be discussed with a clinician.
• It is not addictive and does not appear to cause next-morning grogginess the way antihistamine sleep aids often do.
• Supplements are not FDA-approved, so safety ultimately rides on manufacturing quality — another argument for buying from a manufacturer like NOW that publishes testing.

If you have an inborn error of amino-acid metabolism or any condition affecting glycine handling, supplement only under medical supervision.

How to take it: dosing and timing

The evidence-based protocol is straightforward and easy to replicate with this product:

• Dose: 3 g (about 3/4 of a level teaspoon), matching the dose used in Yamadera 2007 and Bannai 2012. NOW's label suggests a flexible range of 1/4 to 3/4 teaspoon (roughly 1–3 g); for sleep specifically, the studied 3 g is the figure to anchor to.
• Timing: within about 30–60 minutes before bed. The thermoregulatory mechanism fits a pre-sleep window.
• How: dissolve in a few ounces of water or juice. Glycine is water-soluble and faintly sweet, so it mixes easily. The studies used it on its own; you don't need to take it with food.
• What to expect: if it works for you, expect to fall asleep a bit faster and feel somewhat clearer the next day — not heavy sedation. Give it a fair trial of a week or two, and judge it on next-day function as much as on the night itself.

A practical note on the powder vs. capsule choice: NOW sells glycine in 1,000 mg veg capsules too, but you'd need three capsules to hit 3 g, which is more expensive per gram. The powder is the cost-efficient way to take the studied dose.

How much does it cost, and is it good value?

At a typical price around $30 for the 1 lb (454 g) tub with ~151 three-gram servings, the cost per studied 3 g dose is roughly $0.20, and often less at retailers that discount it (prices vary by seller and over time). That's inexpensive for any sleep aid, and it's dramatically cheaper than melatonin gummies, branded "sleep" blends, or prescription hypnotics on a per-night basis.

On value, glycine powder is one of the best price-per-evidence-dollar options in the sleep aisle precisely *because* it's a commodity single ingredient — you're paying for the amino acid, not marketing. The flip side is that "cheap and well-tolerated" doesn't make it "proven." You are buying a low-cost experiment with a plausible mechanism and modest supporting data, not a guaranteed result.

How does it compare to alternatives?

• vs. Melatonin: Different mechanism. Melatonin shifts circadian timing and is best for jet lag or delayed sleep phase; it has more (and more independent) trial data but commonly causes vivid dreams or morning grogginess for some. Glycine targets thermoregulation/sleep onset and tends to be cleaner the next morning, but with weaker, sponsor-heavy evidence.
• vs. Magnesium (glycinate): Magnesium glycinate is, in effect, magnesium bound to glycine; it delivers both but in a fixed ratio and a much smaller glycine amount than 3 g. Pure glycine powder lets you dose the amino acid independently.
• vs. L-theanine / GABA: These target calming/arousal pathways rather than core temperature, with similarly modest evidence. Some people stack glycine with theanine.
• vs. Antihistamine "PM" products (diphenhydramine, doxylamine): Those reliably sedate but cause next-day grogginess, tolerance, and anticholinergic concerns with long-term use; glycine is far gentler but far less potent.
• vs. Prescription hypnotics and CBT-I: For genuine insomnia, neither glycine nor any OTC option matches CBT-I, the guideline-recommended first-line treatment, or prescription therapy when indicated. Glycine sits at the "lifestyle supplement" end, not the treatment end.

Within the specific niche of "single-ingredient glycine powder," NOW's offering is among the most credible because of price, purity, and the manufacturer's testing transparency. Competing bulk glycine powders are often comparable on price but vary in third-party verification.

The bottom line

NOW Foods Glycine Pure Powder is a clean, cheap, well-made way to take the exact 3-gram pre-bed dose used in the small clinical studies on glycine and sleep. The mechanism — accelerating the natural drop in core body temperature that precedes sleep — is biologically plausible and genuinely distinct from melatonin or sedatives, and the gentlest, most realistic claim (slightly faster sleep onset and better next-day alertness, especially after short sleep) is the one with the most support.

But the evidence is modest: small, largely subjective, decades-old studies dominated by a single industry sponsor, with no large independent trial or meta-analysis and no place in first-line insomnia guidelines. The honest framing is that this is a low-cost, low-risk experiment with a sound rationale, not a proven sleep treatment. For occasional mild sleep trouble or to support recovery from a short night, it's a sensible thing to try; for chronic insomnia, prioritize CBT-I and a clinician's input, and treat glycine as an adjunct at most.